Effects of tylosin use on erythromycin resistance in enterococci isolated from swine

Applied and Environmental Microbiology
Charlene R JacksonScott R Ladely

Abstract

The effect of tylosin on erythromycin-resistant enterococci was examined on three farms; farm A used tylosin for growth promotion, farm B used tylosin for treatment of disease, and farm C did not use tylosin for either growth promotion or disease treatment. A total of 1,187 enterococci were isolated from gestation, farrowing, suckling, nursery, and finishing swine from the farms. From a subset of those isolates (n = 662), 59% (124 out of 208), 28% (80 out of 281), and 2% (4 out of 170) were resistant to erythromycin (MIC >/= 8 microg/ml) from farms A, B, and C, respectively. PCR analysis and Southern blotting revealed that 95% (65 out of 68) of isolates chosen from all three farms for further study were positive for ermB, but all were negative for ermA and ermC. By using Southern blotting, ermB was localized to the chromosome in 56 of the isolates while 9 isolates from farms A and B contained ermB on two similar-sized plasmid bands (12 to 16 kb). Pulsed-field gel electrophoresis revealed that the isolates were genetically diverse and represented a heterogeneous population of enterococci. This study suggests that although there was resistance to a greater number of enterococcal isolates on a farm where tylosin was used as a grow...Continue Reading

References

Jan 1, 1991·American Journal of Industrial Medicine·M Greenberg
Jan 1, 1990·Clinical Microbiology Reviews·B E Murray
Jan 1, 1984·British Medical Bulletin·B Weisblum
Mar 1, 1995·Antimicrobial Agents and Chemotherapy·B Weisblum
Sep 1, 1995·Antimicrobial Agents and Chemotherapy·L A ThalM J Zervos
Nov 1, 1996·Antimicrobial Agents and Chemotherapy·J SutcliffeL Wondrack
Mar 21, 1998·Emerging Infectious Diseases·B E Murray
Jun 11, 1998·Emerging Infectious Diseases·M M HuyckeM S Gilmore
Jan 27, 1999·FEMS Microbiology Letters·L B JensenF M Aarestrup
Feb 13, 1999·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·F M Aarestrup, B Carstensen
Dec 3, 1999·Antimicrobial Agents and Chemotherapy·M C RobertsH Seppala
Oct 7, 2000·Antimicrobial Agents and Chemotherapy·L B JensenF M Aarestrup
Nov 4, 2000·Journal of Clinical Microbiology·D TurabelidzeA Sulakvelidze
Sep 6, 2002·Animal Biotechnology·Paula J Fedorka-CrayMarcia L Headrick

❮ Previous
Next ❯

Citations

Oct 15, 2011·Microbial Ecology·Sepideh PakpourMartin R Chénier
Oct 20, 2007·Tropical Animal Health and Production·K Na lampangV Kitikoon
May 27, 2010·Foodborne Pathogens and Disease·Raghavendra G AmachawadiT G Nagaraja
Mar 10, 2011·Foodborne Pathogens and Disease·Jonathan G FryePaula J Fedorka-Cray
Jun 28, 2011·Applied and Environmental Microbiology·R G AmachawadiT G Nagaraja
Jan 5, 2006·Applied and Environmental Microbiology·Artashes R KhachatryanDouglas R Call
Oct 7, 2011·Clinical Microbiology Reviews·Bonnie M Marshall, Stuart B Levy
Feb 14, 2006·The Journal of General and Applied Microbiology·Xavier Vilanova, Anicet R Blanch
Oct 12, 2007·Future Microbiology·Jeffrey M GilbertPatrick F McDermott
Jul 23, 2008·Risk Analysis : an Official Publication of the Society for Risk Analysis·H Scott Hurd, Sasidhar Malladi
Jul 7, 2010·Journal of Applied Microbiology·T RadimerskyI Literak
May 7, 2014·Journal of Applied Microbiology·L J EberhartD R Call
Mar 10, 2016·Journal of Pharmacy & Bioallied Sciences·Funmilola A AyeniWerner Ruppitsch
Feb 13, 2013·Proceedings of the National Academy of Sciences of the United States of America·Yong-Guan ZhuJames M Tiedje
Aug 26, 2010·FEMS Microbiology Ecology·Lakshmikantha H ChannaiahLudek Zurek
Sep 18, 2007·Advances in Applied Microbiology·Katarzyna A Kazimierczak, Karen P Scott
Mar 25, 2019·Microbes and Environments·Hiroshi AsakuraSatoshi Murakami
Jul 29, 2018·Applied and Environmental Microbiology·Mengfei PengDebabrata Biswas
Oct 28, 2019·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Daniel Gyamfi AmoakoSabiha Y Essack
Mar 14, 2021·Applied and Environmental Microbiology·Terence LeeSam Abraham

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.